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to any substance or trauma. He had no associated
areas of hypopigmentations; neither was there any
ocular nor skeletal problem. His mother and younger
sister have similar lesions. He had consulted several
clinics including a leprosy clinic where he was
treated for leprosy with dapsone, a drug he took for 6
months without improvement. The main findings
were multiple facial papules and nodules distributed
on the nose, forehead and malar, with the nodules
m a i n l y o n t h e m i d l i n e ( F i g u r e 1 ) .
Figure1: Photograph of Patient with Multiple
Facial Papules and Nodules.
INTRODUCTION
CASE REPORT
Trichoepitheliomas (TE) are benign cutaneous
tumours that originate from hair follicles and occur
either as solitary non-familial or multiple familial .
The multiple familial trichoepithelioma (MFT) is an
uncommon autosomal dominant disease skin tumour,
characterized by multiple facial papules and nodules
located around the nasolabial area, nose, forehead,
upper lip and occasionally the scalp, neck and upper
trunk .
Histological examination usually shows the typical
horn cysts, tumour islands composed of basophilic
cells arranged in a lace liked network, foreign body
giant cell reaction and some differentiation towards
hair structures .
This is case report of a patient that presented with
multiple facial papules and nodules with a family
history of similar lesions who had histological
diagnosis of Trichoepithelioma (TE).
A 36years single male presented with a 25years
history of painless, non-puritic multiple nodular
facial lesions which were cosmetically unacceptable
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Multiple familial trichoepitheliomas are rare autosomal dominant skin disease that is rarely
reported from this part of the world. The lesions resemble other types of skin diseases that present with papules
and nodules.
This is case report of a patient who presented with multiple facial papules and nodules.
He wanted treatment to improve his facial (cosmetic) appearance.
A 36 year old single male with a 25 years history of multiple facial papules and nodules. Similar
lesions were present in other members of the family. He had several treatments including that for leprosy.
Histologically the lesions showed keratinized stratified squamous epithelium overlying proliferating packets
of basoloid cells with hyper chromatic nuclei, along with several keratin horn cysts and moderate stromal
infiltrate of chronic inflammatory cells. Based on the history and the histology a diagnosis of multiple familial
trichoepithelioma was made.
For a diagnosis of multiple familial trichoepithelioma to be made in patients presenting with
multiple facial papules and nodules a high index of suspicion is needed. This is more so if there is a history of
similar lesions in the family.
Multiple Trichoepithelioma, Familial, Cosmetic appearance, Diagnosis
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antibodies against bcl-2 CD34 that are expressed by
TE are stained by histochemical method according to
their distribution.
Reports have shown that TE can undergo malignant
transformation to BCC . This is a rare occurrence but
it tells the clinician to remain vigilant and to examine
patients carefully as a seemingly benign lesion might
be malignant. This is more so that the lesions tend to
reoccur after surgical treatment .
It has been shown that familial cylindromatosis (FC)
and MFT can occur within one family and a single
person , which suggest that the two types of
dermatosis may be caused by a dysfunction of the
same gene. Based on these facts it has been suggested
that there are two forms of MFT: one that occurs in
isolation is determined by a gene in the region at 9p
and another that co-occurs with FC is determined by a
gene on chromosome 16 the gene . The
has been mapped out by Biggs et al and is located at
chromosome 16q12-13. In a study by Leonard et al
they were able to demonstrate loss of heterozygosity
(LOH) in a patient with sporadic TE at 16q, based on
this Zhang et al and Zheng et al studied the region
of and they were able to demonstrate that the
gene was the genetic basis for MFT in their patients.
The pattern of LOH is characteristic of a tumour
suppressor gene (recessive oncogene), that follows
the classic two-hit model . If the germline
mutations are loss of function mutations and the
second hit (somatic mutation) occurs with equal
chance in eccrine (or apocrine) and hair follicle cells
equally, we expect to see both TE and
cylindromatosis in patients carrying germline
mutation . One hypothesis says that germline
mutation displays tissue specific function loss which
is dependent or independent of the genome
background . Germline mutation may determine the
tissues where the second hit occurred, with
cylindromatosis developing if it happens in eccrine
(or apoccrine) cells and TE when it happens to hair
follicle cells.
Inactivation of the protein may contribute to
oncogenesis by enhancing the degradation of
proteins that suppress cell proliferation or promote
apoptosis . MFT and FC are caused by a gene
encoding the protein. This protein has been
shown to be a deubiquitinating enzyme that
negatively regulates activation o
(nuclear factor- ) by specific tumour
necrosis factor receptors (TNFRs) that are
implicated in the proper development of skin
appendages . The
in inflammation, immune response,
oncogenesis and protection against apoptosis .
Inhibition of increases resistance to apoptosis
(which prevents cell death), a mechanism that has























NF-кB transcription factor has
key role
Histological sections of one of the lesions showed
keratinized stratified squamous epithelium
overlying proliferating packets of basoloid cells with
hyper chromatic nuclei. Several keratin horn cysts in
addition to moderate stromal infiltrate of chronic
inflammatory cells (Figure 2) were seen. Based on
these findings a diagnosis of trichoepithelioma (TE)
was made.
No treatment was offered, as surgical excision will
lead to multiple scars and the effective non surgical
treatment is currently not available in our centre.
Figure 2:
Patients with MFT most often present to the hospital
for cosmetic reason and usually want treatment to
improve their outlook. The lesions are usually dense
and are disfiguring a cause of psycho-social
problem in patients, as seen in our patient who was
not happy with his face even though the lesions were
asymptomatic.
I t i s an uncommon patho logy wi th a
dermatopathology laboratory in the US reporting
about 2.14 to 2.75 cases per year and most of them
are females even though both sexes receive equal
genes (autosomal dominant). Females are most
affected because of the lessened penetrance .
The lesions are skin coloured, firm papules or
nodules of 2-8mm in diameter (fig.1), slow growing
and commonly seen in childhood and adulthood .
It shares similar features with Basal Cell Carcinoma
(BCC) and their distinction may be difficult in small
biopsies . However, this difficulty is mainly in the
solitary TE than in MFT as the family history as well
as the multiple lesions tends to distinguish it
clinically. The main histological features that
distinguish BCC from TE are stroma, clefting and
the absence of papillary mesenchymal branches . In
addition to this, there are histochemical staining
techniques that can also differentiate the two .
Photomicrograph of Papules Showing
the Typical Features of Trichoepithelioma with
the Presence of Keratinized Horn Cells and
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